These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15955222)

  • 1. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability.
    Lee HS; Shun CT; Chiou LL; Chen CH; Huang GT; Sheu JC
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1109-14. PubMed ID: 15955222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sampling variability of liver fibrosis in chronic hepatitis C.
    Bedossa P; Dargère D; Paradis V
    Hepatology; 2003 Dec; 38(6):1449-57. PubMed ID: 14647056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
    Regev A; Berho M; Jeffers LJ; Milikowski C; Molina EG; Pyrsopoulos NT; Feng ZZ; Reddy KR; Schiff ER
    Am J Gastroenterol; 2002 Oct; 97(10):2614-8. PubMed ID: 12385448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.
    Hui AY; Liew CT; Go MY; Chim AM; Chan HL; Leung NW; Sung JJ
    Liver Int; 2004 Dec; 24(6):611-8. PubMed ID: 15566512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies.
    Chevallier M; Guerret S; Chossegros P; Gerard F; Grimaud JA
    Hepatology; 1994 Aug; 20(2):349-55. PubMed ID: 8045495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C.
    Zvibel I; Halfon P; Fishman S; Penaranda G; Leshno M; Or AB; Halpern Z; Oren R
    Liver Int; 2009 Feb; 29(2):208-12. PubMed ID: 18694404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
    Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
    Aliment Pharmacol Ther; 2007 Mar; 25(6):733-9. PubMed ID: 17311607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
    Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M
    J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
    Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
    Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological scoring of fibrosis and activity in HIV-chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slides.
    Wendum D; Lacombe K; Chevallier M; Callard P; Valet F; Miailhes P; Bonnard P; Molina JM; Lascoux-Combe C; Fléjou JF; Girard PM
    J Clin Pathol; 2009 Apr; 62(4):361-3. PubMed ID: 19126564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis: non-invasive assessment with MR elastography.
    Huwart L; Peeters F; Sinkus R; Annet L; Salameh N; ter Beek LC; Horsmans Y; Van Beers BE
    NMR Biomed; 2006 Apr; 19(2):173-9. PubMed ID: 16521091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease.
    Helmreich-Becker I; Schirmacher P; Denzer U; Hensel A; Meyer zum Büschenfelde KH; Lohse AW
    Endoscopy; 2003 Jan; 35(1):55-60. PubMed ID: 12510227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.